Equities

QLM Life & Medical Insurance Company QPSC

QLMI:DSM

QLM Life & Medical Insurance Company QPSC

Actions
FinancialsLife Insurance
  • Price (QAR)1.95
  • Today's Change-0.06 / -2.99%
  • Shares traded2.66k
  • 1 Year change-35.00%
  • Beta0.2073
Data delayed at least 15 minutes, as of Jun 20 2024 11:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

QLM Life & Medical Insurance Company Q.P.S.C. is a Qatar-based Company, which provides medical and life insurance products. The Company’s operating segments include Medical Insurance and Life insurance. Medical Insurance includes Group Medical, which provides optimum, affinity, privilege, and prestige insurance plans, and Individual Medical that provides services to individuals and family members. Life Insurance offers group life, group credit life, and individual life insurance policies. Group Life provides for the policyholder's employees and employees' dependents compensation in the event of the employee's death or other covered risks. Credit Life provide solutions to banks and other financial institutions to protect the borrower and the lender if a loan cannot be repaid because of death or other causes. Individual Life provides financial security to an insured person's family. The Company operates in the Gulf Cooperation Council (GCC) region, including Oman, UAE and Kuwait.

  • Revenue in QAR (TTM)1.19bn
  • Net income in QAR73.69m
  • Incorporated2018
  • Employees--
  • Location
    QLM Life & Medical Insurance Company QPSCQatar Insurance Company (QIC) BuildingTamin Street, West Bay, 666PO BoxDOHA QatarQAT
  • Websitehttps://www.qlm.com.qa/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
QLM Life & Medical Insurance Co QPSC1.19bn73.69m703.50m--9.551.169.380.59280.21050.21053.391.730.9121------5.66----------6.21----5.210.3212---6.73--4.15------
AtlantaSanad SA1.82bn160.06m2.87bn204.0017.913.4714.061.587.267.2682.5137.450.2521------2.112.24--------8.378.03----0.345669.06-8.381.975.7915.6888.5313.70
Data as of Jun 20 2024. Currency figures normalised to QLM Life & Medical Insurance Company QPSC's reporting currency: QAR

Institutional shareholders

7.02%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 31 Dec 202316.10m4.60%
Fiera Capital (UK) Ltd.as of 29 Feb 20246.62m1.89%
Quaestio Capital Management SGR SpAas of 31 Dec 20221.05m0.30%
Ashmore Investment Management Ltd.as of 28 Mar 2024779.02k0.22%
Dimensional Fund Advisors LPas of 31 Jan 202416.64k0.01%
More ▼
Data from 31 Dec 2023 - 31 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.